When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Pneumonia em organização

Última revisão: 11 Dec 2025
Última atualização: 01 Apr 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • doença semelhante à gripe com febre baixa, fadiga e artralgia
Detalhes completos

Outros fatores diagnósticos

  • tosse
  • dispneia
  • estertores bilaterais
Detalhes completos

Fatores de risco

  • pneumonia infecciosa
  • doenças do tecido conjuntivo
  • doenças imunológicas e doença inflamatória intestinal
  • transplante de órgãos
  • uso de medicamentos
  • radioterapia de mama
  • exposição a toxinas
  • vaping
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • radiografia torácica
  • tomografia computadorizada de alta resolução (TCAR) do tórax
  • Hemograma completo
  • velocidade de hemossedimentação
Detalhes completos

Investigações a serem consideradas

  • proteína C-reativa
  • cultura de escarro
  • perfil viral atípico
  • testes de função pulmonar
  • biópsia pulmonar cirúrgica
  • creatina quinase
  • perfil geral de autoimunidade e miosite
  • tomografia por emissão de pósitrons (PET)
  • broncoscopia
Detalhes completos

Algoritmo de tratamento

Inicial

PO rapidamente progressiva

AGUDA

PO criptogênica

PO secundária

CONTÍNUA

PO recorrente, rapidamente progressiva

PO recorrente, não rapidamente progressiva

Colaboradores

Autores

O'Neil Green, MBBS, FCCP

Assistant Professor in Medicine

Director, NTM and Bronchiectasis Clinic

UMass Chan School of Medicine/Baystate Health

Worcester

MA

Declarações

OG has been a consultant to Pharming Inc. and has received research grants from Fisher & Paykel Inc. and Insmed Inc.

Jean-Pierre Assaker, MD

Pulmonary and Critical Care Fellow

UMass Chan School of Medicine/Baystate Health

Worcester

MA

Declarações

JA declares that he has no competing interests.

Agradecimentos

Dr O’Neil Green and Dr Jean-Pierre Assaker would like to gratefully acknowledge Dr Gary R. Epler, the previous contributor to this topic.

Declarações

GRE is an author of several references cited in this topic.

Revisores

Nazia Chaudhuri, MbChB, BSc, PhD, FRCP

Clinical Lead of ILD Service

Manchester University NHS Foundation Trust

Manchester

UK

Declarações

NC declares that she has no competing interests.

Steven Sahn, MD

Professor of Medicine and Director

Division of Pulmonary/Critical Care/Allergy/Sleep Medicine

Medical University of South Carolina

Charleston

SC

Disclosures

SS declares that he has no competing interests.

Teofilo Lee-Chiong, MD

National Jewish Medical and Research Center

Denver

CO

Disclosures

TLC has been reimbursed by the American College of Chest Physicians (ACCP), American Academy of Sleep Medicine, American Thoracic Society, and Cephalon, the manufacturer of modafinil, for attending several conferences. He has been paid by the ACCP for running educational programs and by Elsevier for serving as consultant of the Sleep Medicine Clinics. He has also received research funding from the National Institutes of Health, Respironics, Restore, and Schwarz Pharma, and has been a member of the speakers' bureau for GlaxoSmithKline.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med. 1985 Jan 17;312(3):152-8. Abstract

Epler GR. Bronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options? Expert Rev Respir Med. 2011 Jun;5(3):353-61. Abstract

Bradley B, Branley HM, Egan JJ, et al; British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society. Interstitial lung disease guideline. Thorax. 2008 Sep;63 Suppl 5:v1-58.Full text  Abstract

Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48.Full text  Abstract

Lazor R, Vandevenne A, Pelletier A, et al. Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):571-7.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Pneumonia em organização images
  • Differentials

    • Sarcoidose nodular
    • Pneumonia eosinofílica crônica (PEC)
    • Pneumonia intersticial não específica (PINE)
    More Differentials
  • Guidelines

    • ACR appropriateness criteria: chronic dyspnea-noncardiovascular origin
    • An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
    More Guidelines
  • Patient information

    Pneumonia

    More Patient information
  • Videos

    Estertores inspiratórios tardios

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer